CN110354156A - A kind of myogenic powder formula and its production technology - Google Patents
A kind of myogenic powder formula and its production technology Download PDFInfo
- Publication number
- CN110354156A CN110354156A CN201910747169.6A CN201910747169A CN110354156A CN 110354156 A CN110354156 A CN 110354156A CN 201910747169 A CN201910747169 A CN 201910747169A CN 110354156 A CN110354156 A CN 110354156A
- Authority
- CN
- China
- Prior art keywords
- powder
- gypsum
- formula
- myogenic
- cinnabar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of myogenic powder formulas, including formula as below ratio, gypsum 50-150 mass parts, borneol 5-10 mass parts, cinnabar 5-10 mass parts, Radix Notoginseng powder 3-6 mass parts, this product processing technology is simple, using simple, has the stronger wound healing promoting ability of dredging collateral and promoting blood circulation, festering for liquefaction of fat, skin or mucous membrane, effect is good, there is promotion granulation tissue fast-growth and the less scar in part to be formed, to human body without obvious toxic-side effects.
Description
Technical field
The present invention relates to traditional Chinese medicine formulation art, in particular to a kind of myogenic powder formula and its production technology.
Background technique
Shengji San is external application Chinese medicine prescription, is mainly used for boil and bursts long, and muscle is not given birth to, and the illnesss such as do not close up long, and tradition is raw
Flesh dissipates common drug, and this will be for gypsum and cinnabar, and anastalsis is weaker, and wound healing promoting is indifferent, to liquefaction of fat
Effect is undesirable, to mucocutaneous ulceration or fester it is ineffective, for promoting granulation tissue growth result not affirm, without mitigation
Scar formation effect.
Summary of the invention
The technical problem to be solved by the present invention is to provide a kind of myogenic powder formulas to have dredging collateral and promoting blood circulation stronger using simply
Wound healing promoting ability, for liquefaction of fat, skin or mucous membrane fester effect is good, rapidly promote granulation tissue growth and part
It is formed with scar is mitigated, to human body without obvious toxic-side effects.
The technical solution adopted by the present invention to solve the technical problems is: a kind of myogenic powder formula, including formula as below ratio
Example, gypsum 50-150 mass parts, borneol 5-10 mass parts, cinnabar 5-10 mass parts, Radix Notoginseng powder 3-6 mass parts.
Further, the gypsum is gypsum.
Further, the gypsum includes gypsum and calcined gypsum, the calcined gypsum account for gypsum total mass fraction 0~
33%.
Further, every part of the formula includes gypsum 100g, borneol 8g, cinnabar 8g, Radix Notoginseng powder 6g.
Further, every part of the formula includes gypsum 50g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 3g.
Further, every part of the formula includes gypsum 150g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 6g.
The invention also discloses a kind of production technologies of myogenic powder formula, for producing the above-mentioned myogenic powder formula stated,
Include:
A certain proportion of gypsum, borneol, cinnabar and Radix Notoginseng powder are broken into powder by step 1 respectively;
Gypsum powder, borneol powder, Cinnabar and Radix Notoginseng powder powder are sufficiently mixed uniformly by step 2;
Mixture in step 2 is sieved, removes its thick slag, only stay fine powder by step 3;
Step 4 crushes the filtrate in step 3 again until adding former fine powder mixing at uniformly powdered
In object;
Step 5 packs uniform mixture.
The beneficial effects of the present invention are: this product processing technology is simple, using simple, there is stronger rushs of dredging collateral and promoting blood circulation to hurt
Mouthful healing ability, it is good for liquefaction of fat, skin or mucous membrane effect of festering, to human body without obvious toxic-side effects.
Detailed description of the invention
Fig. 1 is the production technological process of myogenic powder formula.
Specific embodiment
The present invention is further described with reference to the accompanying drawings and detailed description.
This application discloses a kind of myogenic powder formula, including formula as below ratio, gypsum 50-150 mass parts, borneol 5-10
Mass parts, cinnabar 5-10 mass parts, Radix Notoginseng powder 3-6 mass parts;
The stone has the function of cream inducing diaphoresis expelling pathogenic factors from muscles and skin myogenic, gold wound;
The borneol has treatment sore swell and ache curative, the effect that do not hold back after bursting;
The cinnabar has the function of help healthy tendency, promoting blood circulation, sterilization;
The Radix Notoginseng powder has the function of hemostasis, dissipates the stasis of blood, analgesic therapy;
Above-mentioned gypsum selects gypsum, can also add a certain proportion of calcined gypsum in the case where gypsum is inadequate, described
Calcined gypsum accounts for the 0~33% of gypsum total mass fraction.
There is the stronger wound healing promoting ability of dredging collateral and promoting blood circulation by the formula of measurement the application a series of, for fat liquor
Change, skin or mucous membrane fester, and effect is good, can rapidly promote granulation tissue growth and part has mitigation scar formation effect, to people
Body is without obvious toxic-side effects, and the following are specific detection embodiments:
1 gram of Shengji San and Yunnan Baiyao of the invention are equally taken, applied to the liquefaction of fat wound in 3cm, Yunnan Baiyao
Powder is without promotion liquefaction of fat wound healing effect, and Shengji San of the present invention only uses for 1 times/day, can promote wound granulation within 2-3 days
Organize fast-growth.
1 gram of Shengji San and scar plaster one of the invention is equally taken to open, scar plaster is only used for intact skin, and Shengji San can
To apply at once after wound, Shengji San more rapidly promotes wound healing, so that scar is formed after less healing.
Equally take 1 gram of Shengji San of the invention and traditional Shengji San, applied to the wound in same 3cm, life of the invention
Flesh, which dissipates, only needs 1 times/day of use, and wound can heal within 2-3 days, and traditional Shengji San wound healing needs 3-5 days, therefore the present invention
Shengji San promote more traditional Shengji San the time required to wound healing short, hence it is evident that better than traditional Shengji San.
The specific embodiment of above-mentioned formula are as follows:
Embodiment 1:
Every part of the formula includes gypsum 100g, borneol 8g, cinnabar 8g, Radix Notoginseng powder 6g.
Embodiment 2:
Every part of the formula includes gypsum 50g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 3g.
Embodiment 3:
Every part of the formula includes gypsum 150g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 6g.
The invention also discloses a kind of production technologies of myogenic powder formula, for producing the above-mentioned myogenic powder formula stated,
Include:
A certain proportion of gypsum, borneol, cinnabar and Radix Notoginseng powder are broken into powder by step 1 respectively;
Gypsum powder, borneol powder, Cinnabar and Radix Notoginseng powder powder are sufficiently mixed uniformly by step 2;
Mixture in step 2 is sieved, removes its thick slag, only stay fine powder by step 3;
Step 4 crushes the filtrate in step 3 again until adding former fine powder mixing at uniformly powdered
In object;
Step 5 packs uniform mixture.
The production technology that this formula uses also has and uses without using to complicated equipment, processing technology is simple
Simple feature.
Particular embodiments described above has carried out further in detail the purpose of the present invention, technical scheme and beneficial effects
It describes in detail bright, it should be understood that the above is only a specific embodiment of the present invention, is not intended to restrict the invention, it is all
Within the spirit and principles in the present invention, any modification, equivalent substitution, improvement and etc. done should be included in guarantor of the invention
Within the scope of shield.
Claims (7)
1. a kind of myogenic powder formula, it is characterised in that: including formula as below ratio, gypsum 50-150 mass parts, borneol 5-10 matter
Measure part, cinnabar 5-10 mass parts, Radix Notoginseng powder 3-6 mass parts.
2. a kind of myogenic powder formula as described in claim 1, it is characterised in that: the gypsum is gypsum.
3. a kind of myogenic powder formula as described in claim 1, it is characterised in that: the gypsum includes gypsum and calcined gypsum,
The calcined gypsum accounts for the 0~33% of gypsum total mass fraction.
4. a kind of myogenic powder formula as described in any one of claim 2 to 3 claim, it is characterised in that:
Every part of the formula includes gypsum 100g, borneol 8g, cinnabar 8g, Radix Notoginseng powder 6g.
5. a kind of myogenic powder formula as described in any one of claim 2 to 3 claim, it is characterised in that:
Every part of the formula includes gypsum 50g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 3g.
6. a kind of myogenic powder formula as described in any one of claim 2 to 3 claim, it is characterised in that:
Every part of the formula includes gypsum 150g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 6g.
7. a kind of production technology of myogenic powder formula, for producing claim 1 to the life described in any one of claim 6
Flesh powder formula, it is characterised in that:
A certain proportion of gypsum, borneol, cinnabar and Radix Notoginseng powder are broken into powder by step 1 respectively;
Gypsum powder, borneol powder, Cinnabar and Radix Notoginseng powder powder are sufficiently mixed uniformly by step 2;
Mixture in step 2 is sieved, removes its thick slag, only stay fine powder by step 3;
Step 4 crushes the filtrate in step 3 again until adding former fine powder mixture at uniformly powdered
In;
Step 5 packs uniform mixture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910747169.6A CN110354156A (en) | 2019-08-14 | 2019-08-14 | A kind of myogenic powder formula and its production technology |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910747169.6A CN110354156A (en) | 2019-08-14 | 2019-08-14 | A kind of myogenic powder formula and its production technology |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110354156A true CN110354156A (en) | 2019-10-22 |
Family
ID=68223742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910747169.6A Pending CN110354156A (en) | 2019-08-14 | 2019-08-14 | A kind of myogenic powder formula and its production technology |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110354156A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113318128A (en) * | 2021-07-02 | 2021-08-31 | 陕西中医药大学附属医院 | External application wound medicine powder bag |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1131022A (en) * | 1995-03-16 | 1996-09-18 | 李锋 | Qufushengjisan powder medicine capable of removing putrid tissues and promoting growth of new tissues and shengjisan powder |
CN1166973A (en) * | 1996-05-30 | 1997-12-10 | 刘全有 | Multifunctional ointment for treating burn and scald |
CN105148147A (en) * | 2015-10-21 | 2015-12-16 | 覃佳林 | Traditional Chinese medicine for treating wound or bedsore infection and preparation method thereof |
CN109908270A (en) * | 2019-04-30 | 2019-06-21 | 张华利 | A kind of medicament for treating scald |
-
2019
- 2019-08-14 CN CN201910747169.6A patent/CN110354156A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1131022A (en) * | 1995-03-16 | 1996-09-18 | 李锋 | Qufushengjisan powder medicine capable of removing putrid tissues and promoting growth of new tissues and shengjisan powder |
CN1166973A (en) * | 1996-05-30 | 1997-12-10 | 刘全有 | Multifunctional ointment for treating burn and scald |
CN105148147A (en) * | 2015-10-21 | 2015-12-16 | 覃佳林 | Traditional Chinese medicine for treating wound or bedsore infection and preparation method thereof |
CN109908270A (en) * | 2019-04-30 | 2019-06-21 | 张华利 | A kind of medicament for treating scald |
Non-Patent Citations (1)
Title |
---|
余元勋等: "《中国分子中药学》", 30 June 2017, 安徽科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113318128A (en) * | 2021-07-02 | 2021-08-31 | 陕西中医药大学附属医院 | External application wound medicine powder bag |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
CN110354156A (en) | A kind of myogenic powder formula and its production technology | |
CN103341096B (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
CN101926867A (en) | Bone fracture recovering soup | |
CN106177725A (en) | A kind of treat the plaster compositions of mastopathy, purposes and preparation method thereof | |
CN103223076B (en) | Orally taken traditional Chinese medicine treating fractures | |
CN104587226A (en) | Traditional Chinese medicine for treating ankylosing myelitis and lumbar disc herniation and use method thereof | |
CN104491423A (en) | Traditional Chinese medicine composition for stomach and duodenal bulbar ulcers | |
CN100556425C (en) | A kind of Chinese medicine unguentum of analgetic, hemostatic repercussive and sore-arresting functions | |
CN103285203A (en) | Traditional Chinese medicine composition for preventing and treating bone fracture and preparation method thereof | |
CN108066549A (en) | A kind of drug for treating endocrine disorder | |
CN103417788B (en) | One treats fracture Chinese medicine for oral administration | |
CN101181456B (en) | Plaster for curing bone fracture assimilation and preparation method thereof | |
CN104587128B (en) | A kind of medical composition and its use treated first and subtracted | |
CN108553585A (en) | It is a kind of to treat lipoma and fibromatous Chinese medicine preparation and preparation method thereof | |
CN102139088B (en) | Cervical and lumbar vertebrae rehabilitation pill | |
CN1151816C (en) | Fracture setting Chinese medicine capsule for treating bone injury and its prepn process | |
CN105213718A (en) | For the Chinese medicine composition of malignant arrhythmia | |
CN105796860A (en) | Quick-acting bone setting Yi medicine | |
CN105327288A (en) | Drug for treating breast hyperplasia | |
CN104840624A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
CN104547358A (en) | Traditional Chinese medicine preparation for treating spleen-kidney yang deficiency type postmenopausal osteoporosis | |
CN105079204A (en) | Medicine for treating rheumatic and rheumatoid arthritis and preparation method of medicine | |
CN104906276A (en) | Traditional Chinese medicine composition for treating phantom limb pain | |
CN101732408B (en) | Chinese medicament for treating angitis and limb angiopathy and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191022 |